CN103446567B - 一种经前安药物组合物及其制备工艺 - Google Patents
一种经前安药物组合物及其制备工艺 Download PDFInfo
- Publication number
- CN103446567B CN103446567B CN201310391470.0A CN201310391470A CN103446567B CN 103446567 B CN103446567 B CN 103446567B CN 201310391470 A CN201310391470 A CN 201310391470A CN 103446567 B CN103446567 B CN 103446567B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- premenstrual
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 238000000034 method Methods 0.000 title abstract description 3
- 239000000825 pharmaceutical preparation Substances 0.000 title description 2
- 206010036618 Premenstrual syndrome Diseases 0.000 claims abstract description 14
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 7
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 7
- 241001057584 Myrrha Species 0.000 claims abstract description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 241000411851 herbal medicine Species 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 241000195474 Sargassum Species 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 241001474374 Blennius Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 35
- 208000024891 symptom Diseases 0.000 description 18
- 230000005906 menstruation Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000027758 ovulation cycle Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000002175 menstrual effect Effects 0.000 description 7
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 229940071462 oralone Drugs 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000014987 limb edema Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000011599 ovarian follicle development Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
Abstract
Description
组别 | 小鼠数目(只) | 扭体次数(30min) |
生理盐水组 | 30 | 36.1 |
对照药物组 | 30 | 8.6 |
实施例1药物组 | 30 | 2.3 |
项目 | 例数 | 治愈 | 有效 | 无效 | 有效率 |
对照组 | 60 | 37 | 8 | 15 | 75% |
治疗组 | 60 | 48 | 10 | 2 | 97% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310391470.0A CN103446567B (zh) | 2013-08-30 | 2013-08-30 | 一种经前安药物组合物及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310391470.0A CN103446567B (zh) | 2013-08-30 | 2013-08-30 | 一种经前安药物组合物及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103446567A CN103446567A (zh) | 2013-12-18 |
CN103446567B true CN103446567B (zh) | 2015-04-29 |
Family
ID=49729679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310391470.0A Expired - Fee Related CN103446567B (zh) | 2013-08-30 | 2013-08-30 | 一种经前安药物组合物及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103446567B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535665A (zh) * | 2014-04-02 | 2016-05-04 | 王景明 | 一种治疗月经不调的药剂的制备方法 |
CN104740579B (zh) * | 2015-04-12 | 2018-04-06 | 翔宇药业股份有限公司 | 经前安片及其制备工艺 |
CN104740578B (zh) * | 2015-04-12 | 2018-04-06 | 翔宇药业股份有限公司 | 经前安片制备工艺及其检测方法 |
CN105213972A (zh) * | 2015-10-19 | 2016-01-06 | 翔宇药业股份有限公司 | 一种活血通络的药物制剂及其应用 |
CN105213973A (zh) * | 2015-10-19 | 2016-01-06 | 翔宇药业股份有限公司 | 用于缓解女性月经前症状的药物组合物 |
CN106728081B (zh) * | 2016-12-27 | 2020-06-19 | 翔宇药业股份有限公司 | 清浊益肾胶囊的制备方法 |
CN106729405B (zh) * | 2016-12-27 | 2020-06-02 | 翔宇药业股份有限公司 | 用于治疗经前期综合征的药物制剂及其制备方法 |
CN106729406B (zh) * | 2016-12-27 | 2020-06-02 | 翔宇药业股份有限公司 | 经前安制剂的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150023A (zh) * | 1995-11-07 | 1997-05-21 | 罗苓 | 一种治疗妇女产后病的中药 |
CN101584849A (zh) * | 2009-06-16 | 2009-11-25 | 王海荣 | 一种用于治疗经前期紧张综合症的复方当归川芎汤 |
CN102526635A (zh) * | 2012-03-06 | 2012-07-04 | 钟美琴 | 一种治疗经前期紧张综合症的药物及其制备方法 |
CN102716417A (zh) * | 2012-06-15 | 2012-10-10 | 祁连明 | 一种治疗妇科病的中药制剂及其制备方法 |
-
2013
- 2013-08-30 CN CN201310391470.0A patent/CN103446567B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1150023A (zh) * | 1995-11-07 | 1997-05-21 | 罗苓 | 一种治疗妇女产后病的中药 |
CN101584849A (zh) * | 2009-06-16 | 2009-11-25 | 王海荣 | 一种用于治疗经前期紧张综合症的复方当归川芎汤 |
CN102526635A (zh) * | 2012-03-06 | 2012-07-04 | 钟美琴 | 一种治疗经前期紧张综合症的药物及其制备方法 |
CN102716417A (zh) * | 2012-06-15 | 2012-10-10 | 祁连明 | 一种治疗妇科病的中药制剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
从瘀论治月经过少性月经病;刘凤兰等;《现代中医药》;20121130;第32卷(第6期);51-53 * |
黄褐斑的中医药治疗进展;刘树辉等;《中国美容医学》;20070531;第16卷(第5期);706-709 * |
Also Published As
Publication number | Publication date |
---|---|
CN103446567A (zh) | 2013-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103446567B (zh) | 一种经前安药物组合物及其制备工艺 | |
CN100506251C (zh) | 一种治疗乳腺增生的中药制剂及其制备方法 | |
CN105617151A (zh) | 一种煮散型中药抗菌消炎剂及其制备方法和应用 | |
CN102000271A (zh) | 祛除痤疮口服药物 | |
CN102258603B (zh) | 一种治疗浆细胞性乳腺炎的药物制剂及其制备方法 | |
CN103272194A (zh) | 一种治疗妇科月经不调的药物 | |
CN102961719A (zh) | 一种治疗椎管内麻醉后寒战的药剂 | |
CN103919966B (zh) | 一种治疗痤疮的药物 | |
CN105213972A (zh) | 一种活血通络的药物制剂及其应用 | |
CN105213973A (zh) | 用于缓解女性月经前症状的药物组合物 | |
CN104873706A (zh) | 一种治疗宫寒不孕症的中药组合物 | |
CN105194584A (zh) | 一种治疗痛经的药物 | |
CN104208532A (zh) | 一种治疗红皮病型银屑病的药物 | |
CN1965945B (zh) | 藿香薄荷痱子酊 | |
CN103638336B (zh) | 全天麻片 | |
CN103263650A (zh) | 一种调理女性月经的中药 | |
CN104740579B (zh) | 经前安片及其制备工艺 | |
CN102813746B (zh) | 一种用于治疗手指麻木的中药组合物 | |
CN103920010A (zh) | 具有止血止痛及抗炎作用的药物组合物及其制备方法和用途 | |
CN105769790A (zh) | 一种用于治疗经前期紧张和更年期综合征的谷维素片及其制备工艺 | |
CN103386080B (zh) | 一种临床护理脑外伤综合征的药物组合物 | |
CN109771511A (zh) | 一种治疗脾胃湿热型痤疮及酒渣鼻的中药组合物及其制备方法和应用 | |
CN104740578B (zh) | 经前安片制备工艺及其检测方法 | |
CN101983676A (zh) | 一种妇科血瘀气滞疗剂 | |
CN102824611B (zh) | 一种治疗月经失调的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIN FANYOU Effective date: 20140710 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140710 Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant after: Shandong Xiangyu Health Pharmaceutical Co., Ltd. Address before: 276023 Beijing road Shandong Linyi Province, Linyi City Economic Development Zone No. 30 Shandong Xiangyu Health Pharmaceutical Co. Ltd. Applicant before: Lin Fanyou |
|
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant after: Xiang Yu Pharmaceutical limited company Address before: 276023 No. 30, Hangzhou Road, Linyi economic and Technological Development Zone, Linyi, Shandong Applicant before: Shandong Xiangyu Health Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SHANDONG XIANGYU HEALTH PHARMACEUTICAL CO., LTD. TO: XIANGYU PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150429 Termination date: 20190830 |
|
CF01 | Termination of patent right due to non-payment of annual fee |